kentucky semaglutide intestinal paralysis lawyer glp-1 class action gastroparesis attorney kentucky glp-1 gastrointestinal obstruction legal team Kentucky GLP-1 -covingtoncountyhospital-resalathospitallab.ir Ozempic GLP-1 Gastroparesis Lawsuit Once praised as a breakthrough

The study says people prescribed semaglutide, sold under the brands Ozempic for diabetes or Wegovy for weight loss, were more likely to be diagnosed with a rare condition called NAION than those with diabetes or obesity who did not take the medications

Some studies have found that patients taking semaglutide have higher TSH levels compared to those not taking the medication

The biological mechanism by which Ozempic causes gastroparesis is well-established through its primary therapeutic action GLP-1 receptor activation deliberately slows gastric emptying to promote satiety and reduce blood glucose spikes

The sublingual tissues absorb more efficiently when not competing with food particles or excess saliva from recent eating